Follicular lymphoma - rituximab
Rituximab for the treatment of follicular lymphoma (TA110)
Chapter :
1. Guidance
1.1. Rituximab within its licensed indication (that is, in combination with cyclophosphamide, vincristine and prednisolone) is recommended as an option for the treatment of symptomatic stage III and IV follicular lymphoma in previously untreated patients.
